Breast Cancer
AN OPEN-LABEL MULTICENTER PHASE 1b-2 STUDY OF ELACESTRANT IN COMBINATION WITH ABEMACICLIB IN WOMEN AND MEN WITH BRAIN METASTASIS FROM ESTROGEN RECEPTOR POSITIVE, HER-2 NEGATIVE BREAST CANCER (ELECTRA) (ELA-0121)
- Details
ClinicalTrials.gov ID:
NCT05386108
Diagnosis Type:
NA
USOR Number:
- Address
,
P: